Jan 19, 2026 12:00PM

Sep 8, 2025 07:22AM

Aug 25, 2025 10:50AM

May 7, 2025 01:00AM

Apr 10, 2025 06:37AM

Mar 20, 2025 02:00AM

Feb 6, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Valneva SE (VALN)

Jan 22, 2025 11:46AM

Oct 16, 2024 11:47AM

Oct 11, 2024 06:34AM

Sep 4, 2024 07:35AM

Jul 1, 2024 06:40AM

May 31, 2024 11:35AM

Mar 26, 2024 02:00AM Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate

Nov 10, 2023 07:20AM

Sep 7, 2023 05:20AM

Mar 30, 2023 01:00AM

Mar 23, 2023 05:31AM

Mar 23, 2023 02:00AM

Mar 2, 2023 01:00AM

Feb 20, 2023 01:00AM FDA Accepts Valneva’s Chikungunya Vaccine License Application for Priority Review

Feb 17, 2023 05:49AM

Feb 17, 2023 01:00AM

Feb 14, 2023 01:00AM

Dec 30, 2022 12:31PM

Dec 30, 2022 12:30PM

Dec 23, 2022 08:26AM

Dec 23, 2022 01:00AM Valneva Completes BLA Submission to U.S. FDA for its Single-Shot Chikungunya Vaccine Candidate

Dec 6, 2022 01:00AM

Dec 5, 2022 01:00AM

Dec 1, 2022 01:00AM

Nov 10, 2022 01:00AM

Oct 10, 2022 01:00AM

Sep 26, 2022 01:00AM

Sep 16, 2022 04:30PM Valneva and IDT Biologika Agree on Termination of their COVID-19 Collaboration

Sep 6, 2022 01:00AM

Aug 29, 2022 06:05AM

Aug 29, 2022 01:00AM

Aug 23, 2022 11:45AM

Aug 18, 2022 12:00PM

Aug 11, 2022 01:00AM

Aug 8, 2022 04:47PM Pfizer (PFE) and Valneva (VALN) Initiate Phase 3 Study of VLA15

Aug 8, 2022 04:45PM

Aug 8, 2022 04:45PM

Aug 1, 2022 11:45AM

Jul 20, 2022 12:00PM

Jul 20, 2022 12:00PM

Jun 24, 2022 12:00PM

Jun 24, 2022 12:00PM Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001

Jun 24, 2022 01:05AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All